RT Journal Article
SR Electronic
T1 Reliability of retinal pathology quantification in age-related macular degeneration: Implications for clinical trials and machine learning applications
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.09.20210120
DO 10.1101/2020.10.09.20210120
A1 Philipp L. Müller
A1 Bart Liefers
A1 Tim Treis
A1 Filipa Gomes Rodrigues
A1 Abraham Olvera-Barrios
A1 Bobby Paul
A1 Narendra Dhingra
A1 Andrew Lotery
A1 Clare Bailey
A1 Paul Taylor
A1 Clarisa I. Sánchez
A1 Adnan Tufail
YR 2020
UL http://medrxiv.org/content/early/2020/10/13/2020.10.09.20210120.abstract
AB Purpose To investigate the inter-reader agreement for grading of retinal alterations in age-related macular degeneration (AMD) using a reading center setting.Methods In this cross-sectional case series, spectral domain optical coherence tomography (OCT, Topcon 3D OCT, Tokyo, Japan) scans of 112 eyes of 112 patients with neovascular AMD (56 treatment-naive, 56 after three anti-vascular endothelial growth factor injections) were analyzed by four independent readers. Imaging features specific for AMD were annotated using a novel custom-built annotation platform. Dice score, Bland-Altman plots, coefficients of repeatability (CR), coefficients of variation (CV), and intraclass correlation coefficients (ICC) were assessed.Results Loss of ellipsoid zone, pigment epithelium detachment, subretinal fluid, and Drusen were the most abundant features in our cohort. The features subretinal fluid, intraretinal fluid, hypertransmission, descent of the outer plexiform layer, and pigment epithelium detachment showed highest inter-reader agreement, while detection and measures of loss of ellipsoid zone and retinal pigment epithelium were more variable. The agreement on the size and location of the respective annotation was more consistent throughout all features.Conclusions The inter-reader agreement depended on the respective OCT-based feature. A selection of reliable features might provide suitable surrogate markers for disease progression and possible treatment effects focusing on different disease stages.Translational Relevance This might give opportunities to a more time- and cost-effective patient assessment and improved decision-making as well as have implications for clinical trials and training machine learning algorithms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the German Research Foundation (grant # MU4279/2-1 to PLM), the United Kingdom's National Institute for Health Research of Health's Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology. The views expressed are those of the authors, not necessarily those of the Department of Health. The funder had no role in study design, data collection, analysis, or interpretation, or the writing of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board ruled that approval was not required for this study, because all data was completely anonymized before being released to research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData might be made available upon serious request.